Back to Search
REBECCA SCHARF, MD
MD
Internal Medicine Physician
NPI: 1457937211Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
1019579(MA)
Research & Publications (20)
Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors?
PMID 19005247·Audiol Neurootol·2009
8-other
Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA.
PMID 19277426·Thromb Haemost·2009
5-case
Interdisciplinary management of total knee replacement in a haemophilia patient with high-titre inhibitor and severe arthropathy complicated by an aneurysmatic bone cyst.
PMID 19149863·Haemophilia·2009
5-case
Use of recombinant factor VIIa in inherited and acquired von Willebrand disease.
PMID 18263636·Clin Appl Thromb Hemost·2009
6-review
Report on a disease-adapted treatment in a patient with severe factor X deficiency resulting from a homozygous factor X gene mutation.
PMID 18217161·Thromb Haemost·2008
5-case
No evidence for involvement of prothrombotic platelet receptor polymorphisms in acute coronary stent thrombosis.
PMID 17346829·Int J Cardiol·2008
8-other
[Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management].
PMID 19132161·Hamostaseologie·2008
6-review
Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.
PMID 18160568·Clin Appl Thromb Hemost·2008
5-case
Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
PMID 18160590·Clin Appl Thromb Hemost·2008
5-case
Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
PMID 17334521·Thromb Haemost·2007
5-case
Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
PMID 17327284·Nephrol Dial Transplant·2007
8-other
[Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia].
PMID 17938763·Hamostaseologie·2007
6-review
Platelet adhesion onto immobilized fibrinogen under arterial and venous in-vitro flow conditions does not significantly differ between men and women.
PMID 17462088·Thromb J·2007
8-other
HPA-1 polymorphism of alphaIIbbeta3 modulates platelet adhesion onto immobilized fibrinogen in an in-vitro flow system.
PMID 17309793·Thromb J·2007
8-other
Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy.
PMID 16731289·Am J Kidney Dis·2006
6-review
Maternal IVS1-401 T allele of the estrogen receptor alpha is an independent predictor of late fetal loss.
PMID 16753154·Fertil Steril·2006
8-other
Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome.
PMID 16881092·J Rheumatol·2006
5-case
Determination of von Willebrand factor activity: evaluation of the HaemosIL assay in comparison with established procedures.
PMID 16959683·Clin Appl Thromb Hemost·2006
4-observational
The screening power of methylenetetrahydrofolate reductase C677T polymorphism versus plasma homocysteine concentration in patients with stenosis of the internal carotid artery.
PMID 16999862·Thromb J·2006
8-other
Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flow.
PMID 17040572·Thromb J·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 801 MASSACHUSETTS AVENUE, CROSSTOWN 2
BOSTON, MA 02118 - Phone
- (617) 414-7399
Quick Facts
- NPI
- 1457937211
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile